ENTITY
SK Bioscience

SK Bioscience (302440 KS)

176
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
bearishSD Biosensor
21 May 2021 00:19

SD Biosensor IPO Valuation Analysis

Our base case valuation of SD Biosensor is 82,021 won, which is 4% lower than the high end of the IPO price range of 85,000 won. Given the lack of...

Logo
379 Views
Share
bullishSK Bioscience
26 Apr 2021 04:56

KOSPI200 Index Rebalance Preview: Review Period Almost Complete; Short Selling Commences in a Week

There could be up to 6 inclusions and 8 exclusions at the KOSPI200 index review in June. The inclusions could outperform the exclusions as short...

Logo
355 Views
Share
bullishSK Bioscience
25 Apr 2021 10:21

Why NPS Buys SK Bioscience Lately & Lurking Timing for KOSPI 200 Entry Event

This post investigates the recent buying of SK Bioscience by the Korea NPS and discusses the best lurking timing for KOSPI 200 entry event.

Logo
267 Views
Share
bullishLG Corp
23 Apr 2021 09:06

Korea Spin-Offs: Index Treatment

LG Corp, F&F and Ecopro will be suspended from trading on 29 April due to their spin offs. Passive funds will sell stock at the close on 28 April...

Logo
729 Views
Share
bullishSK Bioscience
19 Apr 2021 05:15

SK BioS Lockup Release Today: FO Drop Can Signal a Tight Supply for Passive Mirroring K200

SK Bioscience's lockup releases hit the market today. A substantial drop in FO can signal a tighter supply for passive funds, increasing the...

Logo
229 Views
Share
x